Bioequivalence Study Comparing Two Tablet Formulations of Tebipenem Pivoxil Hydrobromide (TBPM-PI-HBr) in Healthy Adult Subjects
Clinical trial NCT04421885 · COMPLETED
Trial details
- NCT number
- NCT04421885
- Sponsor
- Spero Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-01
- Primary completion
- 2020-07-11
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.